Propranolol tablets are for oral use and are prescribed for high blood pressure, angina, certain heart-rhythm problems, migraine prevention, tremor, and physical symptoms of anxiety. The dose is stated on the pack — follow the leaflet.
The dose is stated on the pack — follow the leaflet. Propranolol belongs to the non-selective beta-blocker class, meaning it blocks beta-1 receptors in the heart and beta-2 receptors in the lungs, blood vessels, and other tissues.
The dose is stated on the pack — follow the leaflet.
Propranolol belongs to the non-selective beta-blocker class, meaning it blocks beta-1 receptors in the heart and beta-2 receptors in the lungs, blood vessels, and other tissues.
This wider receptor action explains both its usefulness and its limits. A slower heart rate can ease palpitations, tremor, and exertional chest discomfort. Blocking beta-2 receptors may also narrow the airways in sensitive people, which is why asthma is a major concern.
The tablet is swallowed whole.
The prescribed dose depends on the condition being treated, resting pulse, blood pressure, age, kidney and liver function, and other medicines. The dose is stated on the pack — follow the leaflet, and the number of tablets and timing are selected for the individual indication.
Typical prescribing patterns include:
A missed dose is not doubled.
If a dose is missed, take it when remembered unless the next scheduled dose is close. Taking two doses together can cause excessive slowing of the heart rate, dizziness, or low blood pressure.
Adrenaline prepares the body for stress by speeding the heart, raising blood pressure, and increasing tremor. Propranolol reduces this response by blocking beta receptors. The heart beats more slowly and with less force. Blood pressure may fall over time. Physical symptoms such as shaking hands, sweating, and a racing pulse can also lessen.
Its effects are usually felt most clearly in the body rather than mood. For anxiety-related use, propranolol may reduce palpitations and tremor without directly treating persistent worry, low mood, or intrusive thoughts.
The World Health Organization includes propranolol in its Model List of Essential Medicines for selected cardiovascular and neurological uses, reflecting its long-established clinical role [1].
It is prescribed for conditions such as high blood pressure, angina, certain heart-rhythm problems, migraine prevention, tremor, and physical symptoms of anxiety.
Beta-blockers share the ability to reduce cardiac workload, yet they differ in receptor selectivity and common clinical uses.
| Medicine | Main receptor activity | Common clinical fit |
|---|---|---|
| Propranolol | Non-selective beta-1 and beta-2 blocker | Tremor, migraine prevention, physical anxiety symptoms, blood-pressure and rhythm control |
| Metoprolol | Mainly beta-1 selective at usual doses | Hypertension, angina, heart-rate control, some heart-failure regimens |
| Atenolol | Mainly beta-1 selective | Hypertension and some heart-rate conditions |
Propranolol is often selected when tremor, migraine prevention, or adrenaline-related symptoms are part of the clinical picture. Metoprolol or atenolol may be preferred when a more heart-selective beta-blocker is needed, especially in people with respiratory disease. No beta-blocker should be switched abruptly or exchanged tablet-for-tablet without a prescriber’s plan.
NICE hypertension guidance describes beta-blockers as selected medicines rather than the routine first option for uncomplicated high blood pressure, because the best choice depends on age, ethnicity, cardiovascular risk, and coexisting conditions [2].
Propranolol is not for you if you have asthma, a history of bronchospasm, severe chronic obstructive airway disease with wheeze, cardiogenic shock, marked bradycardia, second- or third-degree heart block without a pacemaker, severe peripheral arterial disease, or untreated phaeochromocytoma.
Extra caution is needed with:
Relevant interactions include verapamil, diltiazem, amiodarone, digoxin, clonidine, other blood-pressure medicines, some antidepressants such as fluoxetine and paroxetine, and medicines that lower blood sugar. Combining propranolol with verapamil or diltiazem can excessively slow cardiac conduction. If clonidine and propranolol are used together, withdrawal requires a planned sequence because sudden changes can trigger rebound high blood pressure.
The FDA prescribing information warns that propranolol should not be stopped suddenly in people with coronary artery disease, as abrupt withdrawal can worsen angina and may trigger serious cardiac events [3].
This medicine may not be suitable if you have asthma or recurrent wheeze, a very slow heartbeat, certain heart-block problems, severe circulation disease, unstable heart failure, or untreated phaeochromocytoma. Tell your clinician if you have diabetes, liver problems, myasthenia gravis, depression, psoriasis, or are pregnant or breastfeeding. Do not stop it suddenly, particularly if you have coronary artery disease.
Many people tolerate Propranolol well when the dose is introduced carefully. Tiredness, cold hands or feet, sleep disturbance, vivid dreams, dizziness, nausea, and a slower pulse are among the commonly reported effects. Early fatigue can settle after the body adapts, while persistent faintness or breathlessness needs assessment.
A slow pulse can be expected, but marked slowing requires medical review.
More serious effects are less common but require urgent attention. These include wheezing, chest tightness, fainting, severe shortness of breath, a very slow or irregular heartbeat, swelling of the legs with worsening breathlessness, or signs of a severe allergic reaction. People with diabetes may notice that propranolol masks warning signs of low blood sugar, such as tremor and rapid heartbeat, while sweating may still occur.
Propranolol can also reduce exercise heart rate. A lower number during training is expected, but unusual exhaustion, dizziness, chest pain, or inability to recover after modest activity is not a training effect to ignore.
The most frequent problems arise from taking propranolol inconsistently or treating it as a medicine that can be started and stopped casually.
A predictable error is using pulse alone as a measure of wellbeing. Propranolol can lower pulse appropriately while fatigue, wheeze, or dizziness signals that the regimen needs reassessment.
In clinical practice, doctors often value propranolol when a fast pulse, tremor, migraine frequency, or adrenaline-driven physical symptoms are clear treatment targets. The expected result depends on the indication. A person using it for blood pressure may need several weeks and dose adjustments, while someone treated for palpitations may notice a slower pulse much sooner.
Doctors also look beyond the blood-pressure reading. Resting pulse, exercise tolerance, wheeze, sleep quality, glucose control, and fatigue shape the decision to continue, reduce, or change treatment. Propranolol can be a strong fit for one person and unsuitable for another with the same diagnosis.
The main limitation is its non-selective action. People with asthma or recurrent wheeze generally need a different approach.
Propranolol begins affecting heart rate within hours of an oral dose, though the timing varies with the treatment goal. Palpitations, tremor, and adrenaline-related symptoms may improve on the same day. Blood-pressure control and migraine prevention need regular use and may take longer to judge. The FDA’s 2017 propranolol prescribing information describes different dosing schedules across indications, which is why treatment response should be assessed by the prescribing plan rather than one dose.
Propranolol may be prescribed for physical anxiety symptoms such as shaking, sweating, flushing, and a racing heartbeat. It does not directly treat persistent anxious thoughts, panic disorder, or depression in the way psychological therapy or certain psychiatric medicines can. Its role is usually most relevant when adrenaline symptoms are prominent and predictable. The World Health Organization’s 2023 Model List of Essential Medicines describes propranolol’s established cardiovascular and neurological use, while anxiety treatment should be individualised.
Asthma is a major reason to avoid propranolol because its beta-2 blockade can tighten the airways and reduce the response to reliever inhalers. Even mild or intermittent wheeze matters in this decision. New wheezing, chest tightness, or breathlessness after starting treatment needs urgent medical assessment. The European Medicines Agency’s 2017 pharmacovigilance guidance identifies respiratory reactions as clinically significant suspected adverse reactions requiring appropriate reporting and evaluation.
Weight gain is not among the most characteristic effects of propranolol, though reduced exercise tolerance, fatigue, fluid retention from worsening heart failure, or changes in routine can affect body weight. Rapid weight increase together with ankle swelling or breathlessness needs prompt assessment because it may indicate fluid retention rather than body-fat change. NICE guidance issued in 2019 advises that cardiovascular treatment decisions should consider the full clinical picture, not a single symptom or measurement. Consistent monitoring of symptoms is more useful than daily worry about small fluctuations.
Propranolol should not be stopped abruptly, especially in people taking it for angina, rhythm problems, or long-term cardiovascular treatment. Sudden withdrawal can allow adrenaline effects to rebound, raising pulse and blood pressure and worsening chest symptoms. A dose reduction is normally planned over time when treatment needs to end. The FDA safety information published in 2017 specifically warns about abrupt discontinuation in people with coronary artery disease.
Yes. Propranolol can mask warning symptoms of hypoglycaemia, most clearly a fast heartbeat and tremor. Sweating may still occur, but the usual early warning pattern can feel different. This matters most for people using insulin or sulfonylurea medicines. MOHAP pharmacovigilance resources published in 2024 encourage reporting suspected medicine-related problems, including unexpected changes in glucose-warning symptoms.
Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (9.4x4.3x0.3 in. or 24x11x0.7 cm) and its contents cannot be seen.
My pulse had been jumping during stressful meetings and the shaking in my hands was distracting. By the second week it was much less obvious. I felt tired in the afternoons at first, then that eased after I started taking the morning dose with breakfast.
It was prescribed for blood pressure and palpitations. My readings improved gradually, not overnight. The main change I noticed was colder fingers in air-conditioned rooms, which was annoying but manageable.
The physical panic signs reduced, especially the racing heart and voice tremor. I did not like the first dose because I felt light-headed when I stood up quickly, so the timing and dose were adjusted.
It slowed my heart rate but I developed wheezing during a chest infection. My treatment was changed because of my breathing history. The tablet helped the palpitations, but it was not the right match for my lungs.
